TTRX
NASDAQ HealthcareTurn Therapeutics Inc. - Common Stock
Biotechnology
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
๐ Market Data
| Price | $10.72 |
|---|---|
| Volume | 137,690 |
| Market Cap | 325.54M |
| RSI (14-Day) | 39.2 |
| 200-Day MA | $6.97 |
| 50-Day MA | $11.71 |
| 52-Week High | $16.45 |
| 52-Week Low | $2.57 |
| Forward P/E | -71.47 |
| Price / Book | 466.09 |
๐ฏ Investment Strategy Scores
TTRX scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ฐ Dividend Daddy (29/100) โ this strategy High dividend yield + low volatility.
Lowest fit among scored strategies: ๐ Institutional Whale (6/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find TTRX in your text
Paste any article, transcript, or post โ the tool will extract TTRX and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-10-29.